The Inflation Reduction Act is one of the Biden administration’s signature pieces of legislation, and its drug pricing provisions should really deliver significant improvements to America’s pharmaceutical marketplace. New policies will possible influence the base lines of drugmakers, trim margins for pharmacy advantage supervisors, and reduced out-of-pocket expenditures for Medicare […]